Full Text View
Tabular View
Study Results
Related Studies
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks (CHANGE 3)
This study has been completed.
Study NCT00462709   Information provided by ViroPharma

First Received on April 17, 2007.   Last Updated on May 7, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hereditary Angioedema
Additional conditions recognized in this trial
Angioedema
Angioedemas, Hereditary
More general conditions related to this trial
Cardiovascular Diseases
Genetic Diseases, Inborn
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Vascular
Urticaria
Vascular Diseases
Additional drug interventions recognized in this trial
Complement C1
Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein
Complement C1s
More general drug interventions related to this trial
Complement Inactivating Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
ViroPharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services